NCT05924152View on ClinicalTrials.gov

A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 29, 2023

Primary Completion Date

August 9, 2023

Study Completion Date

August 17, 2023

Conditions
Healthy Adults
Interventions
DRUG

Adagrasib

Adagrasib

DRUG

Eltrombopag + adagrasib

Eltrombopag + adagrasib

Trial Locations (1)

32117

Fortrea Clinical Research Unit Daytona Beach (Labcorp Clinical Research Unit Daytona Beach), Daytona Beach

Sponsors
All Listed Sponsors
lead

Mirati Therapeutics Inc.

INDUSTRY

NCT05924152 - A PK Study to Assess the Drug-drug Interaction of a BCRP Inhibitor on Adagrasib | Biotech Hunter | Biotech Hunter